Document Detail


How much is a reduction in morning stiffness worth to patients with rheumatoid arthritis?
MedLine Citation:
PMID:  21529305     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Objective: The aim of this study was to determine the monetary equivalent of the emotional and functional impact of morning stiffness (MS) in patients with rheumatoid arthritis (RA), using alternative valuing methods. Methods: Telephone interviews were conducted among 166 patients with RA to assess utility and clinical symptoms, including MS. Three standard economic methods were used: the human capital approach (HCA), marginal value of time (MVT), and willingness-to-pay (WTP). Results: The monetary equivalent of the impact of MS varied with the method used (from EUR 5.74 to EUR 17.87 per patient per day) and severity of MS (5-8-fold higher in patients with severe MS compared with mild MS). Patients placed considerable value on a reduction in duration and severity of MS. Patients with MS lasting an hour or more were willing to pay EUR 21.74/day to stop the symptom and EUR 10.63/day to halve the duration. Patients with severe MS were willing to pay EUR 47.86/day to stop the symptom and EUR 21.68/day to halve the severity. Conclusions: The observed variation in the monetary equivalent of the impact of MS obtained with the three estimation methods indicates that the findings of studies using different valuing methods should not be compared directly. The study demonstrates that a reduction in MS is worth a considerable amount to patients with RA, particularly those with severe or prolonged MS. These findings suggest that clinical treatment decisions to improve patients' quality of life should also incorporate therapy that reduces MS.
Authors:
R Tuominen; S Tuominen; T Möttönen
Related Documents :
12353065 - Venous thrombosis following the use of intermediate purity fviii concentrate to treat p...
1703105 - Fibrinolytic effect of a particular glycosaminoglycan (endoglycan) per os on normals an...
18617125 - Recombinant factor viia for warfarin-associated intracranial bleeding.
9065995 - Mild hyperhomocysteinemia and hemostatic factors in patients with arterial vascular dis...
9568745 - Cardiovascular disease, fibrinogen and the acute phase response: associations with lipi...
1572115 - Skeletal scintigraphy of pseudo-osteomyelitis in gaucher's disease. two case reports an...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Scandinavian journal of rheumatology. Supplement     Volume:  125     ISSN:  1502-7740     ISO Abbreviation:  Scand. J. Rheumatol. Suppl.     Publication Date:  2011  
Date Detail:
Created Date:  2011-05-02     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0400360     Medline TA:  Scand J Rheumatol Suppl     Country:  England    
Other Details:
Languages:  eng     Pagination:  12-6     Citation Subset:  IM    
Affiliation:
Department of Public Health, University of Turku , Finland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Impact of impaired morning function on the lives and well-being of patients with rheumatoid arthriti...
Next Document:  How should morning function in rheumatoid arthritis be assessed? Bibliographic study of current asse...